ReviewJournal of ovarian research2025
Enhancing PARP inhibitor efficacy in ovarian cancer: targeting the PI3K/AKT/mTOR pathway.
Yixuan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewJournal of ovarian research2025
Yixuan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.